Hubert Dumann

LOW-DOSE INTERLEUKIN-2 INDUCES SYSTEMIC IMMUNE RESPONSES AGAINST HBsAg IN IMMUNODEFICIENT NON-RESPONDERS TO HEPATITIS B VACCINATION

StefanC. Meuer, Hubert Dumann, Karl‐Hermann Meyer zum Büschenfelde · The Lancet · 1989 · 172 citations

Life Sciences, Immunology, Infectious Diseases +10

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure

Hubert Dumann, Stefan Meuer, Karl‐Hermann Meyer zum Büschenfelde · Kidney International · 1990 · 58 citations · Full text

Medicine, Immunology, Nephrology +17

Effect of malnutrition and uremia on impaired cellular host defence.

Marianne Haag–Weber, Hubert Dumann, Hörl Wh · PubMed · 1992 · 34 citations

Life Sciences, Immunology, Nephrology +17